US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 1, 2018 (8 years ago)

Loxapine Capsules, USP 25 mg, packaged in 100 Unit Dose Capsules, Rx only, Manufactured…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination

What was recalled

Loxapine Capsules, USP 25 mg, packaged in 100 Unit Dose Capsules, Rx only, Manufactured by Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. NDC 51079-902-20

Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
NDC code
51079-902-20
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0822-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pine recalls

See all